Mightier Video Games for Emotional Dysregulation
Trial Summary
What is the purpose of this trial?
Access to effective pediatric mental health treatment is a major public health concern in the United States as paucity of pediatric providers leading to long wait times, financial burden, and stigma pose significant barriers to treatment. Digital mental health promises to remedy many chronic problems faced in providing timely and accessible mental health interventions to children. With that in mind, the investigators and Neuromotion Inc. created Mightier, an app-based heart rate biofeedback videogame platform designed to teach and facilitate practice of emotional regulation skills. The technology behind Mightier is backed by three trials showing clinical efficacy and since commercial launch 75% of families who have engaged with the product report improvement. However, Neuromotion's core mission remains increasing access to care, and the direct-to-consumer distribution of digital health also faces access challenges. The investigators propose that access to effective digital mental health interventions can be increased by meeting families where they already know to seek care: the traditional healthcare system. The investigators have partnered with a nationwide behavioral health insurance provider to pilot the integration of Mightier with traditional healthcare. Families will be recruited via direct outreach, social media, or healthcare provider referral. Participating children will be randomized into Mightier or treatment as usual control groups for 6 months. Behavioral healthcare utilization will be observed for 12 months. Through this work the investigators will demonstrate the value of Mightier to various stakeholders via decreased long-term healthcare utilization, confirm that Mightier use results in decreased symptoms of emotional dysregulation, irritability, and parent stress, and explore relationships among Mightier use, healthcare utilization, and symptoms. Ultimately this work will pave the way forward for large scale integration of digital healthcare and more traditional healthcare avenues while simultaneously increasing Mightier's ability to reach children in need.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you have changed your medication or dosage in the past month or plan to change it in the next month.
What data supports the effectiveness of the Mightier video games treatment for emotional dysregulation?
Is the Mightier video game platform safe for use in humans?
How is the Mightier video game treatment different from other treatments for emotional dysregulation?
Mightier video games are unique because they use heart rate biofeedback to help children practice emotional regulation skills while playing, making it an engaging and interactive way to learn emotional control. Unlike traditional therapies, this approach integrates emotional learning into a fun gaming experience, which can be more appealing and accessible for children.138910
Eligibility Criteria
This trial is for children aged 8-12 with emotional dysregulation issues like ADHD or ASD, who have made a behavioral health claim in the past year. They must be fluent in English, have Wi-Fi and a computer or tablet at home. It's not for kids with severe verbal limitations, recent medication changes, psychosis, mania, substance abuse issues, or those highly sensitive to wearing heart rate monitors.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Randomization and Treatment
Participating children are randomized into Mightier or treatment as usual control groups for 6 months
Follow-up
Behavioral healthcare utilization will be observed for 12 months to assess long-term outcomes
Treatment Details
Interventions
- Mightier video games
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neuromotion Labs
Lead Sponsor
Magellan Healthcare
Collaborator
National Institute of Mental Health (NIMH)
Collaborator